Mid to long term outcomes of Laparoscopic Sleeve Gastrectomy in Indian population: 3–7 year results – A retrospective cohort study

Garg, Harshit; Aggarwal, Sandeep; Misra, Mahesh Chandra; Priyadarshini, Pratyusha; Swami, Ashish; Kashyap, Lokesh; Jaiswal, Richa

doi:10.1016/j.ijsu.2017.10.076

Cited by 26 publications

(10 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Kraljevic et al, 52.0%, and in Hauters et al, 80.0% of the LSG cohort with baseline GERD experienced ongoing or worsened reflux at follow-up; of patients without preoperative reflux, 32.4% and 43.0%, respectively, developed de novo GERD in follow-up [ 18 , 20 ]. While there are centers that have reported favorable mid-term LSG outcomes with respect to GERD [ 29 , 30 ], the implications for complications due to both pre-existing and de novo GERD remain among the most important considerations for selection of this procedure. In the present study, about half of the patients reported that they suffered from heartburn or took any drugs to treat heartburn.…”

Section: Discussionmentioning

confidence: 99%

Long-term Reported Outcomes Following Primary Laparoscopic Sleeve Gastrectomy

et al. 2022

View full text Add to dashboard Cite

Background Long-term laparoscopic sleeve gastrectomy (LSG) outcomes in patients with obesity are scarce. We aimed to examine the outcomes and subjective experience of patients who underwent primary LSG with long-term follow-up. Methods The study is a retrospective observational analysis of patients who underwent primary LSG in a single center with 5–15 years of follow-up. Patients’ hospital chart data supplemented by a detailed follow-up online questionnaire and telephone interview were evaluated. Results The study sample included 578 patients (67.0% female) with 8.8 ± 2.5 years of mean follow-up, with a response rate to the survey of 82.8%. Mean baseline age and body mass index (BMI) were 41.9 ± 10.6 years and 42.5 ± 5.5 kg/m 2 , respectively. BMI at nadir was 27.5 ± 4.9 kg/m 2 , corresponding to a mean excess weight loss (EWL) of 86.9 ± 22.8%. Proportion of patients with weight regain, defined as nadir ≥ 50.0% EWL, but at follow-up < 50.0% EWL, was 34.6% ( n = 200) and the mean weight regain from nadir was 13.3 ± 11.1 kg. BMI and EWL at follow-up were 32.6 ± 6.4 kg/m 2 and 58.9 ± 30.1%, respectively. The main reasons for weight regain given by patients included “not following guidelines,” “lack of exercise,” “subjective impression of being able to ingest larger quantities of food in a meal,” and “not meeting with the dietitian.” Resolution of obesity-related conditions at follow-up was reported for hypertension (51.7%), dyslipidemia (58.1%) and type 2 diabetes (72.2%). The majority of patients (62.3%) reported satisfaction with LSG. Conclusions In the long term, primary LSG was associated with satisfactory weight and health outcomes. However, weight regain was notable. Graphical Abstract

show abstract

Section: Discussionmentioning

confidence: 99%

Long-term Reported Outcomes Following Primary Laparoscopic Sleeve Gastrectomy

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Ultimately, 49 original articles were included, as shown in the study flowchart( Table 1 ). [ [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] ].…”

Section: Resultsmentioning

confidence: 99%

“… 36 Genco et al [ 45 ] Gastroesophageal reflux disease and Barrett's esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication 2017 162 45.8 ± 6.3 visual analogue scale (VAS) evaluation of GERD symptoms, PPIs consumption recording, esophagogastroduodenoscopy (EGD) 58 33.6 68.1 48 Georgia et al [ 46 ] 24-h multichannel intraluminal impedance PH-metry 1 year after laparoscopic sleeve gastrectomy: an objective assessment of gastroesophageal reflux disease 2017 12 48.97 24-h multichannel intraluminal impedance-pH metry (MIIpH) pre-and 12 months post-LSG; symptoms; EGD 12 42.06.00 83.33 38 Hendricks et al [ 47 ] Impact of sleeve gastrectomy on gastroesophageal reflux disease in a morbidly obese population undergoing bariatric surgery 2016 919 N.R. symptoms, PPI treatment, upper gastrointestinal endoscopy (UGI), esophagogastroduodenoscopy (EGD), pH manometry 24 group B 1% (13) group A 3% (25) 38 Himpens et al [ 48 ] Long-term results of laparoscopic sleeve gastrectomy for obesity 2010 53 39 (range, 31–57; SD, 5.4) Bariatric analysis and reporting outcome system (BAROS) score 72 3.3 23 34 Hirth et al [ 49 ] Laparoscopic sleeve gastrectomy: long-term weight loss outcomes 2015 16 43.5 medi...…”

Section: Resultsmentioning

confidence: 99%

The new onset of GERD after sleeve gastrectomy: A systematic review

Pavone

Tartaglia

Porfido

et al. 2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

“…24 In a relatively large study including 424 obese patients in India, complete improvement in obstructive sleep apnea, 69.3% improvement in hypertension, 75% improvement in hypothyroidism was shown after LSG. 25 Kikkas and colleagues in a recent investigation have shown that LSG ensured long-term excess weight loss 61.0% at 5 years. They concluded that LSG has a long-term effect on the significant improvement of triglycerides, low-density lipoproteins, and high-density lipoproteins, but not on total cholesterol levels.…”

Section: Discussionmentioning

confidence: 96%

One‐year outcomes of laparoscopic sleeve gastrectomy in morbidly obese patients regarding the age, gender, and postoperative follow‐ups

Tabasi

Farsimadan

Yazdannasab

et al. 2022

Adv in Digestive Medicine

View full text Add to dashboard Cite

The outcome of laparoscopic sleeve gastrectomy (LSG), one of the most common bariatric surgery (BS) procedure, may differ depending on the patient's age, gender, and postoperative follow‐ups. In this study, we aimed to evaluate the efficacy of LSG technique on weight loss, obesity‐associated co‐morbidities and complications in patients undergoing LSG over 3 months and 1 year, regarding their age, gender, and postoperative follow‐ups. The LSG associated complications in participants regarding their preoperative BMI (<39.9 and >39.9), age (30‐40 and 40‐50), and gender were assessed after 3 and 12 months. Besides, the remission and improvement rates of comorbid conditions in patients were examined after 12 months of LSG. Our results showed that LSG led to a significant weight loss in the resolution of obesity‐associated co‐morbidities and different complications after 1 year. No significant difference was found in the improvement and the resolution of obesity‐associated co‐morbidities according to gender. Also, the class 3 patients had significantly higher rates of hearing loss after 12 months and had higher levels of depression and brittle nails 3 months after the surgery. The younger patients also showed a significantly higher percentage of dry skin, intolerance to bread, and menstrual disorder compared to the older group. In conclusion, this study emphasized the importance and necessity of further research into the factors influencing the outcome of LSG such as age, gender, and postoperative follow‐ups.

show abstract

Mid to long term outcomes of Laparoscopic Sleeve Gastrectomy in Indian population: 3–7 year results – A retrospective cohort study

Abstract: LSG has durable weight loss at 5 year with %EWL of 61% and significant resolution of obesity associated co-morbidities.

Cited by 26 publications

References 33 publications

Long-term Reported Outcomes Following Primary Laparoscopic Sleeve Gastrectomy

Long-term Reported Outcomes Following Primary Laparoscopic Sleeve Gastrectomy

The new onset of GERD after sleeve gastrectomy: A systematic review

One‐year outcomes of laparoscopic sleeve gastrectomy in morbidly obese patients regarding the age, gender, and postoperative follow‐ups

Contact Info

Product

Resources

About